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Abstract
Cardiac arrest induces the cessation of cerebral blood flow, which can result in brain damage. The primary intervention
to salvage the brain under such a pathological condition is to restore the cerebral blood flow to the ischemic region.
Ischemia is defined as a reduction in blood flow to a level that is sufficient to alter normal cellular function. Brain tissue
is highly sensitive to ischemia, such that even brief ischemic periods in neurons can initiate a complex sequence
of events that may ultimately culminate in cell death. However, paradoxically, restoration of blood flow can cause
additional damage and exacerbate the neurocognitive deficits in patients who suffered a brain ischemic event, which
is a phenomenon referred to as “reperfusion injury.” Transient brain ischemia following cardiac arrest results from
the complex interplay of multiple pathways including excitotoxicity, acidotoxicity, ionic imbalance, peri-infarct
depolarization, oxidative and nitrative stress, inflammation, and apoptosis. The pathophysiology of post-cardiac arrest
brain injury involves a complex cascade of molecular events, most of which remain unknown. Many lines of evidence
have shown that mitochondria suffer severe damage in response to ischemic injury. Mitochondrial dysfunction based
on the mitochondrial permeability transition after reperfusion, particularly involving the calcineurin/immunophilin
signal transduction pathway, appears to play a pivotal role in the induction of neuronal cell death. The aim of this
article is to discuss the underlying pathophysiology of brain damage, which is a devastating pathological condition,
and highlight the central signal transduction pathway involved in brain damage, which reveals potential targets for
therapeutic intervention.
Keywords: Pathophysiology of ischemic brain damage, Cardiac arrest, Post-cardiac arrest syndrome (PCAS),
Mitochondrial dysfunction, Reperfusion injury, Excitotoxicity, Mitochondrial permeability transition (MPT),
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Introduction
Out-of-hospital cardiac arrest (OHCA) is a common initial
disease in developed countries. According to the latest
report, of the 123,987 patients with OHCA in Japan
brought to the hospital, 75,397 patients were suffering from
a cardiogenic cause. The survival rate of the patients with
bystander at 1 month was 11.9 % and the survival rate to
hospital discharge was only 7.9 % (http://www.fdma.go.jp/
neuter/topics/kyukyukyujo_genkyo/h26/01_kyukyu.pdf).
Patients who achieve return of spontaneous circulation
(ROSC) after OHCA show significant morbidity and
mortality due to the cerebral and cardiac dysfunction
that leads to prolonged whole-body ischemia. This syn-
drome, called the post-cardiac arrest syndrome (PCAS),
comprises anoxic brain injury, post-cardiac arrest myo-
cardial dysfunction, systemic ischemia/reperfusion re-
sponse, and persistent precipitating pathology. Cardiac
arrest is often associated with neurological deterioration.
Although many years of laboratory and clinical research
have been spent, post-cardiac arrest brain injury (PBI), a
key factor of PCAS that involves complex molecular
mechanisms, remains a common cause of morbidity and
mortality. The four key components of PCAS were
identified as (1) PBI, (2) post-cardiac arrest myocardial
dysfunction, (3) systemic ischemia/reperfusion response,
and (4) persistent precipitating pathology [1]. Many stud-
ies have examined the mechanisms involved in ischemic
brain injury. However, no effective pharmacological
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treatment directed at tissues of the central nervous system
(CNS) has been established to prevent the pathological
conditions that occur as a consequence. Therefore, all
aspects of the basic mechanisms responsible for brain
damage require urgent elucidation. Recently, our research
has aimed towards understanding the involvement and
importance of calcium and the calcineurin/immunophilin
signal transduction pathway in brain damage. We previ-
ously demonstrated that immunosuppressants interacting
with the calcineurin/immunophilin signal transduction
pathway show potent neuroprotective effects in several
animal models of ischemic brain damage, and these effects
are considered to be separate from their action on
immunocompetent cells [2–6].
In clinical anesthesiology, the pathological conditions
that involve neuronal degeneration can be broadly
divided into several categories as follows: (i) global ische-
mia due to an extended period of cardiac arrest [7, 8];
(ii) cerebral infarction (focal ischemia) that occurs after
the occlusion of cerebral arteries; (iii) direct injuries due
to head trauma and cerebral compression associated
with hematoma or cerebral edema; (iv) increased intra-
cranial pressure and secondary hypoxic brain damage
due to cerebrovascular spasm; (v) encephalitis or menin-
gitis caused by viruses, bacteria, parasites, fungi, and
spirochetes; and (vi) seizures caused by head trauma,
cerebral tumors, cerebrovascular disorders, intracranial
infections, and abnormal metabolism. This condition is
likely to share many aspects of the pathological mecha-
nisms resulting in brain damage and neurological impair-
ment. Although the most crucial mechanisms responsible
for the induction of brain damage remain unclear, it has
been suggested that mitochondrial dysfunction is sig-
nificantly involved. The elucidation of the basic patho-
physiology for each of these pathological conditions that
involve neuronal degeneration is of great importance for
the development of effective neuroprotective pharmaceut-
ical agents.
In this review, we outline the role of major patho-
physiological disturbances leading to PBI and PCAS due
to cardiac arrest that involve increased intracellular cal-
cium, reactive oxygen species (ROS), and inflammation
in ischemic neuronal cell death, with special emphasis
on the mitochondrial permeability transition (MPT),
which is a pathological state of the inner mitochondrial
membrane leading to bioenergetic failure [9–12].
Review
Pathophysiology of post-cardiac arrest brain injury and
delayed neurodegeneration
At the onset of cardiac arrest, cerebral blood flow tends to
approach zero. In response to the stress of global ische-
mia, various cytokines and complement anaphylatoxins
are synthesized and released. During cardiopulmonary
resuscitation (CPR), blood flow is partially restored. Opti-
mal CPR can restore the cardiac output to between 25
and 40 % of pre-arrest values, while the brain receives
30 % of this amount [13]. After onset of reperfusion, the
activation of blood coagulation leads to the formation of
microemboli, while the activated neutrophils and platelets
accumulate in microvessels [14]. Cerebral microvascular
blood flow may further be compromised by the α1-
adrenergic agonist action of endogenous or exogenous
adrenaline which reduces capillary blood flow and
increases arterial lactate levels [15]. During reperfusion,
the generated ROS intensify endothelial injury, increasing
the exchange vessel’s permeability and microvascular
filtration [14].
After ROSC, a transient increase in circulating cat-
echolamine concentrations results in a normal or ele-
vated blood pressure immediately, and high pressure
periods are needed to overcome the potential no-reflow
phenomenon. Several cytokines, which directly inhibit
adrenal cortisol synthesis and increase the risk of early
refractory shock, are upregulated which promote tissue
damage due to neutrophil infiltration [16]. The ATP-
generating capacity of the mitochondria and energy
charge of the tissue increase and are normalized after
1 h of reperfusion [17]. Lactate accumulation occurs
during cardiac arrest and CPR; it is an essential aerobic
energy substrate and contributes to neuronal integrity
post-ischemia. Lactate is the main oxidizable energy sub-
strate utilized by the brain, at least during the initial mo-
ments after ROSC.
The conditions after ROSC favor the opening of the
mitochondrial permeability transition pore (mtPTP)
which is now characterized by non-specific permea-
bilization of the inner mitochondrial membrane, resulting
in a dramatic swelling of the mitochondria, followed by
disruption of the outer membrane, particularly in the
reperfused tissues [10]. The opening of mtPTP activates
processes that lead to a delayed neuronal death after
24–48 h of recovery.
The levels of various interleukins are intensely in-
creased and reach their peak concentration in the blood
approximately 3 h after ROSC, indicating a “systemic
inflammatory response syndrome” [18] during the early
post-arrest phase. The impact of ischemia/reperfusion
injury on brain injury increases with aging [19]. The im-
pairment of brainstem function in aged patients may
further deteriorate, resulting in increased mortality and
morbidity following cardiac arrest and resuscitation.
Pathophysiological disorders occur from the onset of
cardiac arrest; however, the clinical manifestations of
neuronal degeneration are delayed. Massive functional
neurological impairment may occur after ROSC, and mor-
phological changes in the brain reach maximum levels
after 3 weeks. The pathogenesis of delayed neuronal injury









is further complicated by the fact that it occurs even in
successfully recirculated brains. The post-ischemic hypo-
perfusion syndrome may evolve due to the mismatch be-
tween blood flow and oxygen requirements of the tissue.
Induction of ischemic neuronal cell death—the
glutamate-Ca2+ theory
Ischemia is defined as a reduction in blood flow to a
level that is sufficient to alter normal cellular function.
Brain tissue is highly sensitive to ischemia, such that
even brief ischemic periods in neurons can initiate a
complex sequence of events that may ultimately culmin-
ate in cell death. Different brain regions have varying
thresholds for ischemic cell damage, with the white mat-
ter being more resilient than the gray matter [1]. Dis-
continuation of aerobic metabolism due to cerebral
ischemia provokes the immediate loss of energy sub-
strates, promotes anaerobic glycolysis with the accumu-
lation of intracellular lactic acid and H+, leading to
intracerebral acidosis. Under conditions of hyperglycemia,
intracerebral acidosis is exaggerated. Furthermore, there is
a loss of energy-dependent ion homeostasis primarily
caused by the inhibition of the plasma membrane ATP-
dependent Na+/K+ exchanger, resulting in an increase in
extracellular K+ as well as intracellular Na+, leading to cel-
lular depolarization. The ion gradients that are normally
established across the plasma membrane have many func-
tions, for example, they are used for the removal of excess
intracellular Ca2+ as well as for the re-uptake of extra-
cellular glutamate. These functions are abolished during
ischemia. Moreover, Ca2+ influx via voltage-dependent
Ca2+ channels can contribute to the release of glutamate
from presynaptic terminals to the extracellular space [20].
The excessive release of glutamate further provokes an in-
crease in intracellular Ca2+ and Na+ levels by the binding
of glutamate to its postsynaptic receptors (i.e., N-methyl-
D-aspartate [NMDA] receptors and α-amino-3-hydroxy-
5-methylisoxazole-4-propionic acid [AMPA] receptors).
During ischemia, extracellular calcium concentration
(Ca)e decreases abruptly from about 1.2 mM to about
0.2 mM, demonstrating that virtually all extracellular Ca2+
is taken up by cells [21–23]. This increase in intracellular
Ca2+ and Na+ levels activates the signal transduction
pathways mediated by the activation of Ca2+-dependent
enzymes including nitric oxide synthase, phospholipase
A2, and calmodulin kinase, which then trigger the follow-
ing intracellular events: degradation of lipid membrane
components, an increase in the levels of free fatty acids,
alteration of gene expression, alteration of the phosphoryl-
ation and de-phosphorylation state of proteins, degrad-
ation of proteins of the cytoskeleton, enzymatic and
mitochondrial production of free radicals such as ROS
(e.g., superoxide, hydroxyl radicals, and hydrogen peroxide
(H2O2)) or reactive nitrogen species (Fig. 1). In addition,
the increased intracellular Ca2+ levels will trigger mito-
chondrial dysfunction (described separately below and in
Fig. 2). This results in the deterioration of neuronal cell
membranes and organelles, induction of downstream cas-
cades involving increased Ca2+ cycling and Ca2+ overload
(calcium dysregulation), activation of suicide programs,
disturbance of axonal transport, activation of macro-
phages by the expression of adhesion factors, and platelet
aggregation associated with microvascular dysfunction,
which will eventually lead to unavoidable cell death
(Fig. 3). Clinical manifestations of rapid or delayed neur-
onal degeneration may occur.
This glutamate-Ca2+ theory of excitotoxic neuronal
cell death is widely accepted [24–26]. According to this
theory, the most important aspect of the pathogenesis of
cerebral ischemia is the restriction of substrates and oxy-
gen to the mitochondrial respiratory system and the
induction of cellular ATP crisis. It is the loss of cellular
energy and its repercussions that trigger acute or
delayed neuronal cell death. However, recent analyses of
the role played by heart and liver mitochondria in
reperfusion injury [27, 28] strongly indicate that direct
calcium-triggered mitochondrial dysfunction and neur-
onal cell death associated with the induction of the MPT
may be involved in reperfusion injury under situations of
decreased cellular energy levels (lowered levels of ATP)
and increased oxidative stress (Fig. 4). During the last















Fig. 1 Pathophysiology of post-cardiac arrest syndrome. The four key
components of PCAS were identified as (1) post-cardiac arrest brain
injury, (2) post-cardiac arrest myocardial dysfunction, (3) systemic
ischemia/reperfusion response, and (4) persistent precipitating pathology









10 years, we have investigated and characterized the
MPT in isolated mitochondria from the CNS as well as
examined the role of inhibitors of the MPT in in vivo
models of brain disease. The MPT is an exciting new
putative therapeutic target for intervention in ischemia
reperfusion injury [3, 8, 21, 29–36].
Post-cardiac arrest myocardial dysfunction
Post-cardiac arrest myocardial dysfunction also con-
tributes to the low survival rate [37]; however, this
phenomenon is both responsive to therapy and revers-
ible [13, 38]. Heart rate and blood pressure are ex-
tremely variable due to the transient increase in local
Rehabilitation
Prevent recurrence
Limit ongoing injury organ support
Prognostification
Phase of post-cardiac arrest syndrome
ROSC 20 min 6-12 hours 72 hours Disposition
Immediate Early Intermediate Recovery Rehabilitation
Fig. 2 Relationship to the site of post-cardiac arrest care. Patients with ROSC receive >20-min care during transport or in the ED before hospital
admission. The first 20 min after ROSC is defined as the immediate post-arrest phase. Between 20 min and 6–12 h after ROSC is defined as the
early post-arrest phase. Between 6 and 12 and 72 h is defined as the intermediate phase. A period beyond 3 days is defined as the recovery

































Fig. 3 Calcium overload and the calcineurin/cyclophilin D signal transduction pathway for the cell death induced after cerebral ischemia. Ischemia
induces the loss of ATP-dependent ion homeostasis and leads to an increase in intracellular Na+ and extracellular K+. Eventually, the cells undergo
depolarization. As a result, excessive Ca2+ influx due to the activation of voltage-sensitive calcium channels, NMDA, and AMPA receptors activates
numerous signal transduction cascades, particularly the calcineurin/cyclophilin D signal transduction pathway. This eventually induces the MPT, leading
to mitochondrial dysfunction









and circulating catecholamine concentrations after
ROSC [39]. In one series of 148 patients who underwent
coronary angiography after cardiac arrest, 49 % of the
subjects had myocardial dysfunction manifested by
tachycardia and elevated left ventricular end-diastolic
pressure, followed approximately 6 h later by hypo-
tension (MAP < 75 mmHg) and low cardiac output
(cardiac index <2.2 L min−1 m−2) [13]. Several case series
have described transient myocardial dysfunction after
human cardiac arrest. Cardiac index values reached their
nadir at 8 h after resuscitation, improved substantially
by 24 h, and almost uniformly returned to normal by
72 h in patients who survived OHCA [13]. The res-
ponsiveness of post-cardiac arrest global myocardial
dysfunction to inotropic drugs is well documented in
animal studies [38, 40].
Reperfusion injury and reactive oxygen species (ROS)
It is well known that reperfusion following brain ische-
mia induces the production of a large amount of ROS
ubiquitously throughout a cell. Cardiac arrest represents
the most severe shock state, during which delivery of
oxygen and metabolic substrates is abruptly halted and
metabolites are no longer removed. CPR only partially
reverses this process, achieving cardiac output and sys-
temic oxygen delivery (DO2) that is much less than nor-
mal. During CPR, a compensatory increase in systemic
oxygen extraction occurs, leading to significantly decreased
central (ScvO2) or mixed venous oxygen saturation [22].
The whole-body ischemia/reperfusion of cardiac arrest
with associated oxygen debt causes generalized activation
of immunological and coagulation pathways, increasing the
risk of multiple organ failure and infection [23, 41, 42]. Ac-
tivation of blood coagulation without adequate activation
of endogenous fibrinolysis is an important pathophysio-
logical mechanism that may contribute to microcirculatory
reperfusion disorders [43, 44]. The stress of total body
ischemia/reperfusion affects adrenal function. Although an
increased plasma cortisol level occurs in many patients
after OHCA, relative adrenal insufficiency, defined as
failure to respond to corticotrophin (i.e., <9 μg mL−1
increase in cortisol), is common [45, 46]. Clinical manifes-
tations of a systemic ischemic-reperfusion response include
intravascular volume depletion, impaired vasoregulation,
impaired oxygen delivery and utilization, and increased
susceptibility to infection.
A potentially devastating sequence of reperfusion events
is one in which resumption of oxygen supply leads to
grossly enhanced production of ROS and, thereby, leads
to free radical-mediated damage. The restoration of cere-
bral blood flow, which is known as “reperfusion,” elicits
multiple cellular and physiologic events. Reperfusion
reverses the disruption of cellular functions that was
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Mitochondrial permeability transition (MPT) and ischemic brain damage
Fig. 4 Mitochondrial permeability transition and ischemic brain damage. Various forms of stress, such as brain ischemia, hypoxia, traumatic brain injury,
status epilepticus, and encephalitis, induce mitochondrial dysfunction and the MPT that lead to apoptosis or necrosis. Calcineurin and immunophilin
(CypD) are the key factors that induce the apoptotic pathway, and the immunosuppressants CsA and FK506 exert their neuroprotection by the
inhibition of calcineurin and CypD activity









brain typically result from stroke (caused by either throm-
botic occlusion or rupture of a blood vessel) [47] or car-
diac arrest [48], whereas in infants, cerebral ischemia can
be initiated by complications during delivery, resulting in
neonatal hypoxic-ischemic encephalopathy [49]. Spontan-
eous reperfusion or reperfusion created by an intervention
can cause additional and substantial brain damage, which
is referred to as “reperfusion injury.” Reperfusion induces
pathological events such as lipid peroxidation due to the
elevation of ROS, inflammation, and calcium overload
(calcium dysregulation) that leads to MPT associated with
mitochondrial dysfunction [27, 28, 50, 51] (further dis-
cussed below).
There are a number of possible cellular sources of these
free radicals, including xanthine oxidase, cyclooxygenase,
lipoxygenase, cytochrome p450, endothelial nitric oxide
synthase, and NADPH oxidase. Mitochondria also pro-
duce ROS in the form of a superoxide anion (O2−), H2O2,
and hydroxyl radical (OH−) which have been suggested to
play important roles in the regulation of signal transduc-
tion and cellular metabolism [52]. Alterations of phos-
phorylating (state 3) and basal (state 4) respiration and
respiratory control indicate a normalization of the
electron transport system after reperfusion. However,
secondary mitochondrial dysfunction is a prominent
consequence of transient cerebral ischemia [53] resulting
in a reduction of mitochondrial ATP synthesis. The other
major target of ROS is lipids, and the peroxidative action
of ROS promotes the inactivation of key metabolic
enzymes that regulate glucose metabolism. ROS are
inactivated by endogenous mitochondrial and cytoplasmic
scavenging systems. However, ischemic reperfusion can
sometimes overwhelm these scavenging systems, resulting
in the production of ROS originating primarily from mito-
chondrial complexes I and III of the electron transport
chain, causing oxidative damage to the mitochondria and
consequently the cell [54]. Other highly reactive free
radicals are produced by protein nitrosylation due to the
reaction of NO and superoxide anions, which can also
lead to the dysregulation of cellular homeostasis.
Persistent precipitating pathology
Diagnosis and management of persistent precipitating
pathologies such as acute coronary syndrome (ACS), pul-
monary diseases, hemorrhage, sepsis, and various toxic
syndromes can complicate and be complicated by the
simultaneous pathophysiology of PCAS. Consecutive
patients had no obvious non-cardiac etiology but had
undergone coronary angiography after resuscitation from
OHCA [55]. Nine of the patients with acute coronary
occlusion did not have chest pain or ST segment elevation.
Elevations in troponin T measured during treatment of
cardiac arrest suggest that ACS precedes OHCA in 40 %
of the patients [56]. Another thromboembolic disease to
consider after cardiac arrest is pulmonary embolism.
Pulmonary emboli have been reported in 2–10 % of
sudden deaths [57, 58].
Primary pulmonary diseases such as chronic obstruct-
ive pulmonary disease, asthma, or pneumonia can lead
to respiratory failure and cardiac arrest. When cardiac
arrest is caused by respiratory failure, pulmonary phy-
siology may be worse after restoration of circulation.
Redistribution of blood into pulmonary vasculature can
lead to frank pulmonary edema or at least increased
alveolar-arterial oxygen gradients after cardiac arrest
[59]. Acute brain edema is more common after cardiac
arrest caused by asphyxia [60]. It is possible that perfu-
sion with hypoxemic blood during asphyxia preceding
complete circulatory collapse is harmful.
Sepsis is a cause of cardiac arrest, acute respiratory
distress syndrome, and multiple organ failure. Thus,
there is a predisposition for exacerbation of PCAS when
cardiac arrest occurs in the setting of sepsis. Other pre-
cipitating causes of cardiac arrest may require specific
treatment during the post-cardiac arrest period. For ex-
ample, drug overdose and intoxication may be treated
with specific antidotes, and environmental causes such
as hypothermia may require active temperature control.
Disturbance of mitochondrial Ca2+ homeostasis in
neurons
During ischemia, neuronal Ca2+ channels and trans-
porters as well as glutamate receptors are overactivated,
and the increased activity of plasma membrane Ca2+
channels can then trigger the entry of Ca2+ into the
cytosol, leading to Ca2+ overload. Mitochondria contain
two membranes, an outer membrane permeable to solutes
and an inner membrane impermeable to solutes that har-
bors the respiratory chain complexes. Mitochondria
powerfully sequester Ca2+ to prevent the elevation of cyto-
solic Ca2+, but prolonged depolarization and Ca2+ influx
lead to mitochondrial Ca2+ overload. Mitochondrial Ca2+
overload is induced by three mechanisms: (i) increased
mitochondrial Ca2+ uptake following the release of Ca2+
from the endoplasmic reticulum and Ca2+ influx from the
extracellular space, (ii) reduced Ca2+ extrusion through
the mitochondrial Na+/Ca2+ exchanger, and (iii) changes
in the capacity of mitochondrial Ca2+ buffering [61].
Moderate increases in mitochondrial Ca2+ concentration
are necessary and sufficient to adjust ATP production to
cell demand, but mitochondrial Ca2+ overload leads to the
MPT, which causes the disruption of mitochondrial mem-
brane integrity, irreversible oxidative damage, and the loss
of ATP production, finally resulting in cell death. This
may be achieved by altering the redox state, decreasing
energy demand, or supplying the cells with pharmaco-
logical inhibitors of the MPT, such as cyclophilin inhibi-
tors [62] (see also below).










This phenomenon occurs very rapidly and is more
robust during reperfusion. The inflammatory reaction of
the blood vessels occurs immediately after vessel
occlusion and induces the activation of platelets and
endothelial cells. The expression of adhesion molecules
including selectins, intercellular adhesion molecules, and
vascular cell adhesion molecules is induced by the adhe-
sion of neutrophils initially and then later monocytes to
the endothelium. Brain ischemia induces an inflamma-
tory reaction that leads to mitochondrial damage [63].
Activated leukocytes contribute to blood vessel occlu-
sion, which disturbs vascular patency and releases proin-
flammatory cytokines, proteases, and ROS that induce
vascular damage at the endothelial surface, leading to
thrombus formation, vasospasm, and breakdown of the
blood-brain barrier, further promoting the infiltration of
leukocytes into the brain. Activation of microglia, which
are the resident tissue macrophages, occurs within mi-
nutes of the onset of ischemia. After neuronal cell death,
danger-associated molecular pattern molecules activate
the pattern recognition receptors, including the Toll-like
receptors expressed on microglia, and contribute to the
inflammatory response in brain ischemia. Microglia also
produce ROS that can cause mutations in mitochondrial
DNA and damage the enzymes of the respiratory chain,
leading to dysfunction of oxidative phosphorylation and
increased ROS production [64]. The early inflammatory
response therefore appears to induce the secondary
failure of bioenergetic function.
Molecular mechanisms of the mitochondrial permeability
transition (MPT)
The MPT was traditionally considered to be mediated
by the formation of an MPT pore, which is a dynamic
complex of several proteins. This protein complex was
proposed to be located at the contact sites between the
inner and outer mitochondrial membranes, which are
sites important for metabolic regulation as well as inter-
action with the cytosol, intermembrane space, and the
matrix compartments [65, 66]. It is still unclear whether
the elevation of mitochondrial matrix Ca2+ levels during
ischemia is causally related to the neuronal cell death
that occurs after cerebral ischemia. The current general
hypothesis is that the MPT is formed by the voltage-
dependent anion channel (VDAC or porin) of the outer
membrane, the adenine nucleotide translocase (ANT) of
the inner membrane, and cyclophilin D (CypD) located
in the matrix compartment [66]. However, a recent gene
deletion study has questioned the role of VDAC as an
essential component and regulator of the MPT [67].
The increased permeability of the inner mitochondrial
membrane can also possibly be induced by the con-
certed action of other proteins such as the uncoupling
proteins and the Tom/Tim transport system, as well as
by the aggregation of misfolded membrane proteins.
However, the proposed core components of the MPT
pore, in particular ANT and CypD, are likely to be the
proteins involved in the MPT phenomenon during
calcium overload under pathophysiological conditions.
Hansson et al. reported that adult-viable human brain
and liver mitochondria possess an active CypD-sensitive
mtPTP and that CypD inhibition plays an important role
for neuroprotection [68–70].
In summary, the obligate molecular components of
the MPT have not yet been resolved. Initially, there was
the hypothesis that the MPT requires a complex con-
sisting of the inner membrane protein ANT, the outer
membrane component VDAC/porin, and the matrix
modulator CypD.
Critical role of the MPT in neurodegeneration
The loss of ATP; an increase in the levels of calcium,
phosphate, and free fatty acids; and the generation of
free radicals are key factors in inducing the MPT (Fig. 4).
The proton gradient and the mitochondrial membrane
potential (ΔΨm) are rapidly lost as the hydrogen ions
extruded from the mitochondria by the electron trans-
port chain rapidly fall back through the MPT pores,
uncoupling oxidation of metabolic substrates and res-
piration from the phosphorylation of ADP. The con-
sequences of the MPT are dramatic when the inner
membrane rapidly becomes permeable to solutes of up
to 1500 Da (Fig. 4). Importantly, this transition, if
prolonged, can affect respiration in different ways ac-
cording to the substrate being oxidized. Induction of the
MPT in mitochondria energized with complex-I-linked
substrates is followed by complete respiratory inhibition
due to the loss of pyridine nucleotides [71, 72]. In-
duction of the MPT in mitochondria energized with
complex-II-linked substrates is followed by uncoupling.
The mitochondrial matrix is dense in proteins, and the
induction of the MPT pores will result in an osmotic
influx of water into the matrix, causing the inner mem-
brane to unfold and expand, resulting in mitochondrial
swelling, as well as causing the outer membrane to rup-
ture, inducing the release of proapoptotic proteins such
as cytochrome c [73, 74] and apoptosis-inducing factors
Omi and Smac (Fig. 4). Prolonged and extensive MPT
will lead to the termination of ATP production and nec-
rotic cell death, if the energy balance cannot be compen-
sated by anaerobic metabolism.
Calcineurin and cell death
Calcineurin was first discovered by Wang et al. in 1976
as an inhibitor of calmodulin (CaM)-dependent cyclic
phosphodiesterase [75]. Calcineurin is abundantly dis-
tributed in the hippocampus, striatum, and cerebral









cortex. Subcellularly, it is primarily found bound to the
cell membrane or the cytoskeletal elements and is
enriched in postsynaptic densities. Calcineurin is best
known as being a target for the widely used immunosup-
pressive molecules cyclosporin-A (CsA) and tacrolimus
(FK506) [76]. Under physiological conditions, the effects
of calcineurin are greatly multifaceted, for example, it
can dephosphorylate NMDA receptors, IP3 receptors,
and ryanodine receptors, which are all relevant to the
regulation of intracellular Ca2+ levels. Shibasaki et al.
demonstrated the interaction between members of the
antiapoptotic Bcl-2 protein family and calcineurin
activity, indicating an important role for calcineurin in
the regulation of apoptosis [77]. They furthermore
demonstrated that calcineurin specifically participates in
a Ca2+-inducible mechanism for apoptosis induction by
regulating BAD (a proapoptotic Bcl-2 protein family
member) phosphorylation [78] (see Fig. 4).
Conclusions
Mechanisms of brain injury due to cardiac arrest and
delayed neuronal death that occurs over hours to days
after ROSC remain unknown. The pathophysiology of
PCAS involves a complex cascade of molecular events,
most of which are still unknown. Many lines of research
evidence have shown that mitochondria suffer severe
damage in response to ischemic injury. Mitochondrial
dysfunction based on the MPT after reperfusion, par-
ticularly involving the calcineurin/immunophilin signal
transduction pathway, appears to play a critical role in
the induction of brain injury following cardiac arrest.
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